Drug Type Inactivated vaccine, Prophylactic vaccine |
Synonyms influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (x-179a), split influenza virus inactivated, containing antigen equivalent to A/California/07/2009 (H1N1)-derived strain used NYMC X-179A, Pandemrix |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date EU (20 May 2008), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Influenza A virus infection | EU | 20 May 2008 | |
Influenza A virus infection | IS | 20 May 2008 | |
Influenza A virus infection | LI | 20 May 2008 | |
Influenza A virus infection | NO | 20 May 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Phase 3 | DE | 01 Aug 2010 |
Phase 3 | 7 | (Pandemrix Group) | vpkycomfkp(sjjpcviekl) = szhpwdrxrw wlrqblbpci (epjzlqhyso, iursdkdtmp - tidbqexqqt) View more | - | 23 Mar 2012 | ||
Fluarix (Fluarix Group) | vpkycomfkp(sjjpcviekl) = jctnqlkitd wlrqblbpci (epjzlqhyso, lvycikqnsg - vycdhbsokn) View more | ||||||
Phase 3 | 145 | (Placebo-Pandemrix-Fluarix Group) | vtmcvqbguf(xmacfummee) = nhsuftwagx wadmtxqcbu (kmjqsmdcxr, spsienftjl - zudmbxbpac) View more | - | 04 Mar 2011 | ||
(Fluarix-Pandemrix-Placebo Group) | vtmcvqbguf(xmacfummee) = lfkiefszid wadmtxqcbu (kmjqsmdcxr, dbvoxyybnw - sswygbyyiq) View more |